• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

编码人蛋白酶激活受体2的基因的分子克隆与功能表达

Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2.

作者信息

Nystedt S, Emilsson K, Larsson A K, Strömbeck B, Sundelin J

机构信息

Division of Molecular Neurobiology, Wallenberg Laboratory, Lund University, Sweden.

出版信息

Eur J Biochem. 1995 Aug 15;232(1):84-9. doi: 10.1111/j.1432-1033.1995.tb20784.x.

DOI:10.1111/j.1432-1033.1995.tb20784.x
PMID:7556175
Abstract

We previously reported the molecular cloning of a mouse guanosine-nucleotide-binding-protein-coupled receptor similar to the thrombin receptor. Since the physiological agonist was unknown, the receptor was named proteinase-activated receptor 2. We describe here the cloning and functional expression of the gene encoding the corresponding human receptor. The gene is divided into two exons separated by about 14 kb intronic DNA. The deduced protein sequence is 397 amino acids long and 83% identical to the mouse receptor sequence. Within the extracellular amino terminus, the residues predicted to form the tethered agonist ligand differ between the two receptors; of the first six residues only four are conserved. At positions five and six, a lysine residue and a valine residue, respectively, have replaced arginine and leucine residues found in the mouse sequence. When the human receptor is expressed in Chinese hamster ovary cells, it can be activated by low nanomolar concentrations of the serine proteinase trypsin and by peptides made from the receptor sequence. Northern-blot analysis of receptor expression showed that the receptor transcript is widely expressed in human tissues with especially high levels in pancreas, liver, kidney, small intestine and colon. Moderate expression was detected in many organs but none in brain or skeletal muscle. By fluorescence in situ hybridization, the human proteinase-activated receptor 2 gene was mapped to chromosomal region 5q13, where, previously, the related thrombin receptor gene has been located.

摘要

我们先前报道了一种与凝血酶受体相似的小鼠鸟苷酸结合蛋白偶联受体的分子克隆。由于其生理激动剂未知,该受体被命名为蛋白酶激活受体2。我们在此描述编码相应人类受体的基因的克隆及功能表达。该基因分为两个外显子,中间间隔约14kb的内含子DNA。推导的蛋白质序列长397个氨基酸,与小鼠受体序列的同源性为83%。在细胞外氨基末端,预测形成拴系激动剂配体的残基在两种受体之间存在差异;前六个残基中只有四个是保守的。在第五和第六位,赖氨酸残基和缬氨酸残基分别取代了小鼠序列中的精氨酸和亮氨酸残基。当人类受体在中国仓鼠卵巢细胞中表达时,它可被低纳摩尔浓度的丝氨酸蛋白酶胰蛋白酶以及由受体序列制成的肽激活。受体表达的Northern印迹分析表明,受体转录本在人类组织中广泛表达,在胰腺、肝脏、肾脏、小肠和结肠中水平尤其高。在许多器官中检测到中等水平的表达,但在脑或骨骼肌中未检测到表达。通过荧光原位杂交,人类蛋白酶激活受体2基因被定位到染色体区域5q13,先前相关的凝血酶受体基因也位于该区域。

相似文献

1
Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2.编码人蛋白酶激活受体2的基因的分子克隆与功能表达
Eur J Biochem. 1995 Aug 15;232(1):84-9. doi: 10.1111/j.1432-1033.1995.tb20784.x.
2
Conserved structure and adjacent location of the thrombin receptor and protease-activated receptor 2 genes define a protease-activated receptor gene cluster.凝血酶受体和蛋白酶激活受体2基因的保守结构及相邻位置定义了一个蛋白酶激活受体基因簇。
Mol Med. 1996 May;2(3):349-57.
3
The mouse proteinase-activated receptor-2 cDNA and gene. Molecular cloning and functional expression.小鼠蛋白酶激活受体-2的互补DNA及基因。分子克隆与功能表达。
J Biol Chem. 1995 Mar 17;270(11):5950-55. doi: 10.1074/jbc.270.11.5950.
4
Cloning and characterization of human protease-activated receptor 4.人蛋白酶激活受体4的克隆与特性分析
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6642-6. doi: 10.1073/pnas.95.12.6642.
5
Molecular cloning of a potential proteinase activated receptor.
Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9208-12. doi: 10.1073/pnas.91.20.9208.
6
The human proteinase-activated receptor-3 (PAR-3) gene. Identification within a Par gene cluster and characterization in vascular endothelial cells and platelets.人类蛋白酶激活受体-3(PAR-3)基因。在Par基因簇中的鉴定及其在血管内皮细胞和血小板中的特性研究。
J Biol Chem. 1998 Jun 12;273(24):15061-8. doi: 10.1074/jbc.273.24.15061.
7
Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2.人蛋白酶激活受体-2的分子克隆、表达及潜在功能
Biochem J. 1996 Mar 15;314 ( Pt 3)(Pt 3):1009-16. doi: 10.1042/bj3141009.
8
Selective tryptic cleavage at the tethered ligand site of the amino terminal domain of proteinase-activated receptor-2 in intact cells.完整细胞中蛋白酶激活受体-2氨基末端结构域的拴系配体位点处的选择性胰蛋白酶切割。
J Pharmacol Exp Ther. 2003 Mar;304(3):1120-8. doi: 10.1124/jpet.102.043844.
9
cDNA cloning and expression of a hamster alpha-thrombin receptor coupled to Ca2+ mobilization.
FEBS Lett. 1991 Aug 19;288(1-2):123-8. doi: 10.1016/0014-5793(91)81017-3.
10
Rat proteinase-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue.大鼠蛋白酶激活受体-2(PAR-2):胃和血管组织中受体衍生肽的cDNA序列及活性
Br J Pharmacol. 1996 Jun;118(3):521-30. doi: 10.1111/j.1476-5381.1996.tb15433.x.

引用本文的文献

1
A disintegrin-like and metalloproteinase 15 facilitates glioblastoma proliferation and metastasis through activation of the protease-activated receptor 1.去整合素样金属蛋白酶15通过激活蛋白酶激活受体1促进胶质母细胞瘤的增殖和转移。
Cytojournal. 2025 Mar 13;22:34. doi: 10.25259/Cytojournal_92_2024. eCollection 2025.
2
The Many Faces of Protease-Activated Receptor 2 in Kidney Injury.蛋白酶激活受体2在肾损伤中的多种表现
Biomedicines. 2025 Feb 8;13(2):414. doi: 10.3390/biomedicines13020414.
3
Protease activated receptor 2 as a novel druggable target for the treatment of metabolic dysfunction-associated fatty liver disease and cancer.
蛋白酶激活受体 2 作为一种新的可药物治疗代谢功能障碍相关脂肪性肝病和癌症的靶点。
Front Immunol. 2024 Oct 11;15:1397441. doi: 10.3389/fimmu.2024.1397441. eCollection 2024.
4
Coagulation protease-induced extracellular vesicles: their potential effects on coagulation and inflammation.凝血蛋白酶诱导的细胞外囊泡:它们对凝血和炎症的潜在影响。
J Thromb Haemost. 2024 Nov;22(11):2976-2990. doi: 10.1016/j.jtha.2024.07.022. Epub 2024 Aug 8.
5
Coagulation Protease-Driven Cancer Immune Evasion: Potential Targets for Cancer Immunotherapy.凝血蛋白酶驱动的癌症免疫逃逸:癌症免疫治疗的潜在靶点
Cancers (Basel). 2024 Apr 19;16(8):1568. doi: 10.3390/cancers16081568.
6
Protease-activated receptors in health and disease.蛋白酶激活受体在健康和疾病中的作用。
Physiol Rev. 2023 Jan 1;103(1):717-785. doi: 10.1152/physrev.00044.2021. Epub 2022 Jul 28.
7
Protease Activated Receptor 1 and Its Ligands as Main Regulators of the Regeneration of Peripheral Nerves.蛋白酶激活受体 1 及其配体作为周围神经再生的主要调节剂。
Biomolecules. 2021 Nov 10;11(11):1668. doi: 10.3390/biom11111668.
8
Trypsin-Like Proteases and Their Role in Muco-Obstructive Lung Diseases.胰蛋白酶样蛋白酶及其在黏液阻塞性肺疾病中的作用。
Int J Mol Sci. 2021 May 29;22(11):5817. doi: 10.3390/ijms22115817.
9
Legumain Induces Oral Cancer Pain by Biased Agonism of Protease-Activated Receptor-2.Legumain 通过偏倚性激动蛋白酶激活受体-2 诱导口腔癌痛。
J Neurosci. 2021 Jan 6;41(1):193-210. doi: 10.1523/JNEUROSCI.1211-20.2020. Epub 2020 Nov 10.
10
The domino effect triggered by the tethered ligand of the protease activated receptors.由蛋白酶激活受体的连接配体引发的级联反应。
Thromb Res. 2020 Dec;196:87-98. doi: 10.1016/j.thromres.2020.08.004. Epub 2020 Aug 4.